Tricitrates Oral Solution
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Tricitrates Oral Solution is a solution of Sodium Citrate, Potassium Citrate, and Citric Acid in a suitable aqueous medium. It contains, in each 100 mL, NLT 2.23 g and NMT 2.46 g of sodium (Na), equivalent to NLT 9.5 g and NMT 10.5 g of sodium citrate dihydrate (C6H5Na3O7 · 2H2O); NLT 3.78 g and NMT 4.18 g of potassium (K), equivalent to NLT 10.45 g and NMT 11.55 g of potassium citrate monohydrate (C6H5K3O7 · H2O); NLT 12.20 g and NMT 13.48 g of citrate (C6H5O7) as sodium citrate and potassium citrate; and NLT 6.34 g and NMT 7.02 g of citric acid monohydrate (C6H8O7 · H2O). [NOTE-The sodium and potassium ion contents of Tricitrates Oral Solution are each approximately 1 mEq/mL.]
2 IDENTIFICATION
A. IDENTIFICATION TESTS GENERAL, (191)
Sample: 2 mL Oral Solution
Acceptance criteria: Meets the requirements for test A under Sodium
B.
Sample solution: Oral Solution (1 in 20)
Analysis: Add 5 mL of sodium cobaltinitrite TS to 2 mL of Sample solution.
Acceptance criteria: A yellow precipitate is formed immediately (presence of potassium).
C. The retention time of the citrate peak of the Sample solution corresponds to that of Standard solution 1, as obtained in the Assay for Citric Acid.
3 ASSAY
3.1 SODIUM AND POTASSIUM
Sodium stock solution: Transfer 14.61 g of sodium chloride, previously dried at 105° for 2 h, to a 250-mL volumetric flask, and dilute with water to volume.
Potassium stock solution: Transfer 18.64 g of potassium chloride, previously dried at 105° for 2 h, to a 250-ml volumetric flask, and dilute with water to volume.
Diluent: Transfer 1.04 g of lithium nitrate to a 1000-mL volumetric flask, add a suitable nonionic surfactant, then add water to volume. This solution contains 15 mEq of Li/1000 mL..
Standard solution: Pipet 50 mL of Sodium stock solution and 50 mL of Potassium stock solution into a 500-mL volumetric flask, and dilute with water to volume. Each mL of this solution contains 0.1 mEq of sodium (Na) and 0.1 mEq of potassium (K). Transfer 50 µL of this solution to a 10-mL volumetric flask, and dilute with Diluent to volume.
Sample solution: Transfer a volume of Oral Solution, equivalent to 2 g of combined citrates, to a 100-mL volumetric flask, and dilute with water to volume. Transfer 50 µL of this solution to a 10-mL volumetric flask, and dilute with Diluent to volume.
Instrumental conditions
(See Atomic Absorption Spectroscopy (852).)
Mode: Atomic absorption spectrophotometry
Analytical wavelengths
Sodium emission line: 589 nm
Potassium emission line: 766 nm
Blank: Diluent
Analysis
Samples: Standard solution, Sample solution, and Blank
Calculate the quantity, in g, of sodium (Na) in the portion of Oral Solution taken:
Result = (Ar /Mr ) × (RU,Na /RS,Na ) × (W/F)
Ar = atomic weight of sodium, 22.99
Mr = molecular weight of sodium chloride, 58.44
RU,Na = sodium emission reading from the Sample solution
RS,Na = sodium emission reading from the Standard solution
W = weight of sodium chloride in the Sodium stock solution, 14.61 g
F = conversion factor, 25
Calculate the quantity, in g, of potassium (K) in the portion of Oral Solution taken:
Result = (Ar /Mr ) × (Ru,k /Rs,k ) × (W/F)
Ar = atomic weight of potassium, 39.10
Mr = molecular weight of potassium chloride, 74.55
Ru,s = potassium emission reading from the Sample solution
Rs,k = potassium emission reading from the Standard solution
W = weight of potassium chloride in the Potassium stock solution, 18.64 g
F = conversion factor, 25
Acceptance criteria: 2.23–2.46 g/100 mL of sodium and 9.5–10.5 g/100 mL of potassium
3.2 CITRATE
Mobile phase, Standard solution 1, Chromatographic system, and System suitability: Proceed as directed in Assay for Citric Acid/Citrate and
Phosphate (345).
Sample solution: Transfer an appropriate volume of Oral Solution into a suitable volumetric flask, and proceed as directed in Assay for Citric Acid/Citrate and Phosphate (345). Sample solution (for the assay of citric acid/citrate).
Analysis: Proceed as directed in Assay for Citric Acid/Citrate and Phosphate (345), Procedure.
Calculate the concentration, in g/100 mL, of citrate (C6H5O7) in the portion of Oral Solution taken:
Result = [(ru /rs ) × (Cs /Cu ) − A(Mr1 /Mr2 )] × L
ru = citrate peak area from the Sample solution
rs = citrate peak area from Standard solution 1
Cs = concentration of citrate in Standard solution 1 (µg/mL)
Cu = nominal concentration of Sample solution
A = concentration of citric acid monohydrate determined in the Assay for Citric Acid (mg/mL)
Mr1 = molecular weight of citrate, 189.10
Mr2 = molecular weight of citric acid monohydrate, 210.14
L = Oral Solution label claim (g/100 mL)
Acceptance criteria: 12.20–13.48 g/100 mL as sodium citrate and potassium citrate
3.3 CITRIC ACID
Sample solution: Transfer 15 ml of Oral Solution into a 250-mL volumetric flask, and dilute with water to volume.
Analysis: Transfer 5 mL of the Sample solution into a suitable flask, and add 25 mL of water and 5 drops of phenolphthalein TS. Titrate with 0.02 N sodium hydroxide VS to a pink endpoint. Each mL of 0.02 N sodium hydroxide is equivalent to 1.401 mg of citric acid monohydrate (C6H8O7 · H2O)
Acceptance criteria: 6.34-7.02 g/100 mL
4 SPECIFIC TESTS
PH (791); 4.9-5.4
5 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight containers.
USP REFERENCE STANDARDS (11)
USP Citric Acid RS

